Articles
This is the first article in a 4-part series on bendamustine. This article describes the history and characterization of bendamustine. Subsequent articles will discuss the efficacy and safety of bendamustine in registration studies and describe ongoing clinical investigations of bendamustine. Read More ›
I am enthusiastic about this 6-part series titled Conquering the Cancer Care Continuum. Each edition of CCCC will address an important topic in oncology management and offer expert stakeholder commentaries. Read More ›
This, the first issue in the second annual Conquering the Cancer Care Continuum series, focuses on palliation in cancer care. Future articles in the series will explore oncology pain management, hospice care options, treatment planning through the cancer care continuum, survivorship care programs, and the role of biosimilars in supportive care. Read More ›
The evolution of drug research and development toward oral therapies for cancer over the past decade has created a number of questions for the oncology healthcare provider. Read More ›
It is well documented that healthcare costs and spending have been growing at staggering rates. Healthcare accounts for ~17% of total gross domestic product (GDP) in the United States. Read More ›
Dr Hansen’s article brings to light financial aspects of healthcare that we do not often consider. A recent economic analysis showed the total cost of cancer care in the US reached $209.9 billion in 2005. Read More ›
A large percentage of male cancer patients are not receiving appropriate fertility advice. Read More ›
Researchers recently released comprehensive retrospective study results comparing the major types of prostate cancer treatments in terms of saving lives and cost-effectiveness. Read More ›
Overall cancer death rates continued to decline in the United States among both men and women. Read More ›
In the quest to prevent colon cancer, researchers developed a vaccine that effectively stimulated the immune system to respond to early indications of colon cancer in patients at high risk for the disease. Read More ›